These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26491847)

  • 1. Pre- and Posttreatment Glioma: Comparison of Amide Proton Transfer Imaging with MR Spectroscopy for Biomarkers of Tumor Proliferation.
    Park JE; Kim HS; Park KJ; Kim SJ; Kim JH; Smith SA
    Radiology; 2016 Feb; 278(2):514-23. PubMed ID: 26491847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histogram Analysis of Amide Proton Transfer Imaging to Identify Contrast-enhancing Low-Grade Brain Tumor That Mimics High-Grade Tumor: Increased Accuracy of MR Perfusion.
    Park JE; Kim HS; Park KJ; Choi CG; Kim SJ
    Radiology; 2015 Oct; 277(1):151-61. PubMed ID: 25910226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amide proton transfer imaging seems to provide higher diagnostic performance in post-treatment high-grade gliomas than methionine positron emission tomography.
    Park JE; Lee JY; Kim HS; Oh JY; Jung SC; Kim SJ; Keupp J; Oh M; Kim JS
    Eur Radiol; 2018 Aug; 28(8):3285-3295. PubMed ID: 29488086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging.
    Su C; Liu C; Zhao L; Jiang J; Zhang J; Li S; Zhu W; Wang J
    AJNR Am J Neuroradiol; 2017 Sep; 38(9):1702-1709. PubMed ID: 28729292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance between contrast enhancement, proton MR spectroscopy, and amide proton transfer imaging in patients with brain tumors.
    Sakata A; Fushimi Y; Okada T; Arakawa Y; Kunieda T; Minamiguchi S; Kido A; Sakashita N; Miyamoto S; Togashi K
    J Magn Reson Imaging; 2017 Sep; 46(3):732-739. PubMed ID: 28252822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
    Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
    Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Added value of amide proton transfer imaging to conventional and perfusion MR imaging for evaluating the treatment response of newly diagnosed glioblastoma.
    Park KJ; Kim HS; Park JE; Shim WH; Kim SJ; Smith SA
    Eur Radiol; 2016 Dec; 26(12):4390-4403. PubMed ID: 26883333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience.
    Anselmi M; Catalucci A; Felli V; Vellucci V; Di Sibio A; Gravina GL; Di Staso M; Di Cesare E; Masciocchi C
    Neuroradiol J; 2017 Jun; 30(3):240-252. PubMed ID: 28627984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
    Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
    J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton MR spectroscopy in predicting the increase of perfusion MR imaging for WHO grade II gliomas.
    Guillevin R; Menuel C; Abud L; Costalat R; Capelle L; Hoang-Xuan K; Habas C; Chiras J; Vallée JN
    J Magn Reson Imaging; 2012 Mar; 35(3):543-50. PubMed ID: 22045581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
    Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
    Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.
    Fink JR; Carr RB; Matsusue E; Iyer RS; Rockhill JK; Haynor DR; Maravilla KR
    J Magn Reson Imaging; 2012 Jan; 35(1):56-63. PubMed ID: 22002882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
    Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
    Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study.
    Matsumura A; Isobe T; Anno I; Takano S; Kawamura H
    J Clin Neurosci; 2005 May; 12(4):416-20. PubMed ID: 15925772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
    Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
    Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of MR spectroscopy for assessment of glioma grading.
    Bulik M; Jancalek R; Vanicek J; Skoch A; Mechl M
    Clin Neurol Neurosurg; 2013 Feb; 115(2):146-53. PubMed ID: 23237636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Differentiation of Low-Grade and High-Grade Gliomas and Detection of Tumor Proliferation Using APT Contrast Fitted from Z-Spectrum.
    Zhang J; Zhu W; Tain R; Zhou XJ; Cai K
    Mol Imaging Biol; 2018 Aug; 20(4):623-631. PubMed ID: 29313159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttreatment high-grade glioma: usefulness of peak height position with semiquantitative MR perfusion histogram analysis in an entire contrast-enhanced lesion for predicting volume fraction of recurrence.
    Kim HS; Kim JH; Kim SH; Cho KG; Kim SY
    Radiology; 2010 Sep; 256(3):906-15. PubMed ID: 20634429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.